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esponsibility of Xi’Abstract Two common analytical chemical problems often encountered when using chromato-
graphic techniques in drug analysis are matrix interferences and ion suppression. Common sample
preparation often involves the dilution of the sample prior to injection onto an instrument, especially
for liquid chromatography–mass spectrometry (LC–MS) analyses. This practice frequently does not
minimize or eliminate conditions that may cause ion-suppression and therefore, suffer more from
reduced method robustness. In order to achieve higher quality results and minimize possible
interferences, various sample preparation techniques may be considered. Through the use of
QuEChERS (“catchers”), a novel sample preparation technique used for high aqueous content
samples, benzodiazepines can be extracted from biological ﬂuids, such as blood and urine. This
approach has shown increased recoveries of target compounds when using quantiﬁcation by both
external and internal standard. This increase in the recoveries has been attributed to a matrix
enhancement and was determined through the use of the method of standard addition. While
improving the overall analytical method for gas chromatography–mass spectrometry (GC–MS)
analysis, it is not clear if this approach represents an overall beneﬁt for laboratories that have both
GC–MS and high performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS)
capability. Demonstrating evidence of variable ionization (enhancement, ion source inertness, etc.),
the method of quantiﬁcation should be focused on in future studies.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.sity. Production and hosting by Elsev
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an Jiaotong University.1. Introduction
Benzodiazepines constitute a large and important class of phar-
maceuticals displaying antiepileptic, hypnotic, tranquillizing,
anticonvulsant, sedative, muscle relaxant, and amnesic properties
[1]. They have been shown to be useful in treating a variety of
neurological problems such as anxiety, insomnia, agitation,
seizures and muscle spasms, as well as alcohol withdrawal [2].ier B.V. All rights reserved.
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of the most frequently prescribed anxiolytic drugs worldwide [3].
The benzodiazepine parent structure consists of a 1,4-diazepine
fused with a benzene ring, which is termed as a 1,4-benzodiaze-
pine, Fig. 1 [4]. As a synthetic drug having pharmacological
properties, benzodiazepines are listed as a schedule IV drug in the
United States.
All benzodiazepines share the same mechanism of action,
which is the modulation of γ-aminobutyric acid (GABA) uptake;
the principle inhibitory neurotransmitter in the brain [2,5–7]. Once
bound, the benzodiazepine locks the GABA receptor into a
conformation with much higher afﬁnity for the neurotransmitter
and enhances ion conduction, resulting in the reduction of neural
excitability [2].
There are two main concerns associated with benzodiazepine
detection: their elimination half-lives and their metabolism. While
the original drug's duration in the system may not be long, their
metabolites may remain in the system for an extended period of
time. Benzodiazepines are mainly metabolized in the liver by
cytochrome P450 isoenzymes which produce dealkylated and
hydroxylated analogs of the parent compound; several of which
still retain strong pharmacological properties, Fig. 2 [8]. Most of
these resultant metabolites tend to exist as other commonly used
and prescribed benzodiazepines.
Benzodiazepines are one of the most widely prescribed medica-
tions in the United States and are becoming more frequently
encountered on the illicit market [9]. When used alone, benzodia-
zepines carry an extremely low risk of acute toxicity; however,
they are often used with other drugs of abuse, which can enhanceFig. 1 Parent structure of 1,4-benzodiazepine.
Fig. 2 Diazepam and its three mainthe toxic effects of benzodiazepines [10]. Due to their excessive
utilization and their implication in many cases of multi-drug abuse,
benzodiazepines are often found in fatal cases of drug intoxication.
Their abuse is also on the increase with young illicit drug users.
These young abusers are taking large doses which cause profound
behavioral effects and can lead to dependence. Some benzodiaze-
pines, such as ﬂunitrazepam, are deliberately misused in case of
chemical submission during sexual assault. The misuse and abuse
of these drugs may increase the potential for experiencing negative
drug interactions as well as the possibility of drug overdose. Given
that benzodiazepines are widely used in clinical and forensic cases,
the availability of rapid, sensitive, and selective analytical methods
for their determination in biological ﬂuids and pharmaceutical
formulations is imperative [11–13].
Drug analysis of biological ﬂuids (serum, plasma, urine) usually
requires considerable preparation of the samples before they
are injected into a chromatographic system for analysis [14].
The identiﬁcation and conﬁrmation of drugs of abuse requires an
analytical technique that is highly sensitive and subjective of the
different drugs.
The extraction of analytes from complex media is important
because it isolates the analyte(s) of interest. Most of analytical
methods attempt to minimize sample preparation steps to minimize
costs and the time spent on the sample workup. Previous
extraction methods for benzodiazepines include solid–phase
extraction (SPE) and liquid–liquid extraction (LLE).
Current laboratory methods employ SPE sample preparation
followed by liquid chromatography mass spectrometry (LC–MS).
The use of SPE to isolate benzodiazepines from biological samples
appears to be efﬁcient, but this methodology carries along with it
many disadvantages including irreversible adsorption of analytes
on the packing, more complex method development, and batch-to-
batch variability [15]. The utilization of LC–MS methods is also
associated with various limitations, such as signiﬁcant time and
effort involved in sample preparation, low screening capacity for
target contaminants, and insufﬁcient capabilities for structural
identiﬁcation of non-target contaminants [16]. In addition to its
limitations, one common concern with LC–MS analysis is ion
suppression. Ion suppression is a matrix effect that negatively
affects detection capability, and therefore precision and accuracypharmacological metabolites [8].
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of diluted samples. This often requires considerable instrumental
maintenance [18,19]. Without performing a sample preparation
step there is a possibility for reduced data quality, which is of
extreme concern in the ﬁeld of Forensic Science.
Anastassiades and Lehotay developed the QuEChERS (“catch-
ers”) method; which stands for quick, easy, cheap, effective,
rugged, and safe [20]. The development of the QuEChERS method
was designed to improve conventional sample preparation for
multi-residue pesticide analysis. Researchers were looking for a
simple, effective, and inexpensive way to extract and clean
pesticide residues from the many varied sample matrices that
worked with routinely. The QuEChERS methodology was found
to be an effective alternative. The key to this new approach is the
ability to amend the dispersive solid-phase extraction (d-SPE)
sorbents. The dispersive act allows for the distribution of the salts
to diffuse throughout the entire sample for a more thorough
extraction. This research methodology focused on sorbents that
assist in the clean-up of the biological matrix and extraction of
benzodiazepines.Table 1 Benzodiazepines of interest.
Benzodiazepine Acronym Brand name pKa
Clonazepam CLON Klonopins 1.5
Diazepam DIA Valiums 3.3
Flunitrazepam FLU Rohypnols 1.5
Medazepam MED Nobrium, Rudotels 6.2
aMaximum recommended therapeutic dose (MRTD) value for adults exp
[27].
Fig. 3 Chromatogram of diazepam (extracted ion: 256) illustrating the d
samples from one extraction set.Since the development of the QuEChERS method, its applica-
tion has been introduced to a variety of analytes and matrices.
These other applications include the extraction of antibiotics [21],
pharmaceuticals [22], and veterinary drugs [23,24] in biological
samples or food products. Very recently the QuEChERS method
has caught the attention of the forensic chemistry community. The
research represented currently has shown that this extraction
method can be used for benzodiazepines, in biological matrices
such as blood and urine.2. Materials and methods
2.1. Chemicals and materials
Internal (cocaine-d3, 1000 ng/mL) and recovery (diazepam-d5,
1000 ng/mL) standards were purchased from Cerilliants (Round
Rock, TX). Cocaine-d3, while structurally dissimilar to benzodia-
zepines, was utilized as the internal standard due to its availability
and its pKa, which is intermediate between the relatively wideSpiked concentration (ng/mL) MRTDa (mg/kg-bw/day)
2.98 0.133
3.45 0.667
3.30 0.0333
2.80 n/a
ressed in milligram/kilogram of body weight per day (mg/kg-bw/day)
ifferences in retention time and abundance between water and blood
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interfering masses with the target benzodiazepines, and should
function well as a gas chromatography mass spectrometry
(GC–MS) internal standard. Diazepam-d5 was employed as the
recovery standard because it would mimic the behavior of the
benzodiazepines throughout the extraction process.
Benzodiazepine standard stock solutions (of approximately
1000 ng/mL) were prepared from neat material purchased from
Alltechs (Deerﬁeld, IL) and Grace (Columbia, MD). All
reagents (acetonitrile, ammonium hydroxide, and anhydrous
magnesium sulfate) were obtained from Avantor™ Perfor-
mance Materials, Inc. (Phillipsburg, NJ). Sodium chloride was
obtained from BDHs Chemicals (Radnor, PA). All chromato-
graphic consumables and graphitized carbon black (GCB) were
obtained from Restek Corporation (Bellefonte, PA). All 50 mL
and 1.7 mL centrifuge tubes along with all urine collection
cups were purchased from Denville Scientiﬁc Incorporated
(Metuchen, NJ).
2.2. The QuEChERS methodology
Previously developed methodology was employed for the sample
preparation (both pre-dispersive and d-SPE) [24]. Pre-dispersive
extraction began with 10 mL of sample (representative of 10 g
water (18.2 MΩ), blood, deﬁbrillated sheep's blood; or human
urine) was pipetted into a 50 mL centrifuge tube. It should be
noted that 10 mL is on the large side of a reasonable sample size,
but it is expected that the sample size can be cut down pending
initial results.
A selected benzodiazepine was added to a 10 mL sample along
with a recovery standard (diazepam-d5). 10 mL of acetonitrile
(ACN) was pipetted into the sample's 50 mL centrifuge tube. The
sample was vortexed for 1 min on a ﬁxed vortex mixer at
maximum speed. The aqueous sample was then transferred into
another 50 mL centrifuge tube containing nominally 4 g anhydrousFig. 4 Chromatogram of medazepam (extracted ion: 242) illustrating the
samples from one extraction set.magnesium sulfate (MgSO4; which helps bind large amounts of
water) and nominally 1 g sodium chloride (NaCl; which increases
the ionic strength of the aqueous phase and induces a phase
separation). The sample was then directly vortexed for 1 min
(note: this step prevents the formation of MgSO4 conglomerates
[25]). Finally, the sample was centrifuged for 5 min at 3000 rpm.
The organic layer was transferred from the 50 mL centrifuge tube
to a screw capped vial and set aside for analysis. The d-SPE
involved obtaining a 1 mL aliquot of the organic layer which was
pipetted into a 1.8 mL centrifuge tube containing nominally
0.150 g anhydrous MgSO4 and nominally 0.025 g graphitized
carbon black (GCB). The sorbents help remove residual water and
remove matrix interferents for an improved clean-up. The sample
was vortexed for 30 s, then centrifuged for 3 min at approximately
5000 rpm on an Eppendorf Centrifuge 5415C. The sample was
transferred from the centrifuge tube to a screw cap vial and set
aside for analysis. There were three rounds of extractions
conducted for each sample (the reported results are averaged
between the extractions).
2.3. Analysis
2.3.1. Chromatography
SPE along with LC–MS has been a typical method for the analysis
of benzodiazepines because of their polarity and non-volatility. This,
however, does not mean that benzodiazepines are not amend-
able to other chromatographic techniques. For this research
study, benzodiazepines extracted via QuEChERS methodology
were analyzed by GC–MS without derivatization. The detection
of low concentrations (especially in forensics) is of signiﬁcant
interest since the determination of trace analytes is often the
main objective. Based on the techniques advantages, GC–MS
provided the sensitivity for these trace analytes; and also an
improvement in chromatographic resolution compared to those
appearing in LC–MS.differences in retention time and abundance between water and blood
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Quantiﬁcation was performed and compared using calibration
standards involving both internal standard and method of
standard additions (MSA). The internal standard was added to
each sample analysis vial just prior to instrumental analysis.Fig. 5 Chromatogram of ﬂunitrazepam (extracted ion: 312) illustratin
extraction set.
Table 2 Average retention timea and retention time shifts of
benzodiazepines in different matrices.
Water Blood Urine
Benzodiazepine Avg. tr (min) Avg. tr (min) Avg. tr (min)
Diazepam 14.089 14.081 14.062
Flunitrazepam 14.790 14.779 14.761
Medazepam 13.224 13.216 13.191
aAverage retention time includes the averages of both the pre-
dispersive and the dSPE steps.
Table 3 Response factors and relative standard deviation of benzod
Matrix Extraction RF
Clonazepam
H2O Pre-dSPE n/a
dSPE n/a
Blood Pre-dSPE 7.9
dSPE 8.5
Urine Pre-dSPE n/a
dSPE n/a
Avg. RF 8.20
% RSD 5.17The internal standard quantiﬁcation allowed for the use of a
correction based upon the response factor (RF) of each target
compound.
The use of MSA allows for more accurate concentration results,
especially if there is a bias occurring due to the sample matrix
[26]. For MSA quantiﬁcation, standards were added to separate
sample vials in increasing concentrations for each benzodiazepine
prior to analysis.2.3.3. GC–MS
Extracts were analyzed using an Agilent Technologies 7890A GC,
coupled to a 5975C mass spectrometer. The inlet system was
operated in splitless mode with a 1 mL injection volume. The system
was equipped with a Restek SKY injection liner (drilled uniliner,
hole near top; 4 mm 6.3 mm 78.5 mm). Helium was used as the
carrier gas with a constant ﬂow rate of 1 mL/min. Separation was
performed on a Restek Rxis-5Sil MS column (30 m 0.25 mm-g the difference in retention time in the urine samples from one
iazepines of interest.
Diazepam Flunitrazepam Medazepam
6.38 5.03 4.03
5.05 3.80 2.46
8.13 9.28 4.25
8.48 9.06 3.98
4.15 3.68 2.26
4.63 4.32 2.24
6.14 5.86 3.20
29.98 44.48 30.44
J.L. Westland, F.L. Dorman514ID 0.25 mm). The injector temperature was set to 250 1C and an
oven temperature gradient was applied starting from 40 1C (1 min) to
340 1C (10 min) at a ramp rate of 20 1C/min. The mass spectrometer
acquisition mode was set to scan and the acquisition frequency was
2.91 scans/s. The mass range was from 50 to 550 amu.3. Results
Factors affecting quantiﬁcation and recovery of benzodiazepines
from varying matrices via pre-dSPE and d-SPE clean-ups were
examined. Table 1 shows the benzodiazepines of interest used in
this work. These analytes were chosen as they are suitable probesFig. 6 Chromatogram of the internal standard (ISTD) in medazepam samp
abundance in the water, blood, and urine matrices.
Fig. 7 Chromatogram of internal standard (ISTD) throughout one entire
and stability of the analysis.for evaluation of analytical methodology for a larger list of
benzodiazepines. The analysis of the initial data indicated some
concern with ion enhancement and shifts in the retention times of
the target compounds. Figs. 3 and 4 show the chromatograms of
diazepam and medazepam, respectively, extracted from both water
and blood matrices. The known concentrations in each of the
samples were below the standard at 5 ng/mL. A noticeable
difference in peak areas was observed and thought to be caused
by the sample matrix. It was also observed that there was an
increase in abundance of the extracted benzodiazepine from blood
compared to water which was thought to be caused by ion
enhancement, or another ion-source-related artifact. Another con-
cern observed was a shift in the retention times, which appeared toles (extracted ion: 85) illustrating the differences in retention time and
urine extraction set (extracted ion: 85), illustrating the reproducibility
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that the extractions of the blood samples eluted earlier than those
from the water samples. Fig. 5 shows the chromatograms of
ﬂunitrazepam extracted from urine.
Table 3 shows the average response factors (RFs) for
each sample (clonazepam, diazepam, ﬂunitrazepam, and medaze-
pam) in each of the three matrices (water, blood, and urine). These
average RF values show the intra-lab reproducibility of the
replications. Figs. 6 and 7 also display the retention time
consistency of the internal standard in the different matrices.
Quantiﬁcation and recovery data are shown in Table 4. Quanti-
ﬁcation was conducted by external standard, internal standard
(response factor), and comparison of single-point peak areas.
These quantiﬁcations displayed a trend of ion enhancement and
thus an increase in recovery. In order to rule out ion enhancement,
MSA quantiﬁcation was conducted (Table 5).4. Discussion
Initial research demonstrated the ability of the QuEChERS to be
applied to the extraction of benzodiazepines in biological ﬂuids.Table 4 Concentrations and percent recovery of unknowns based on
Sample External STD Interna
Concentration (ng/mL) Recovery (%) Concen
Clonazepam
Blood
Pre-dSPE 9.25 310 7.73
dSPE 9.54 320 8.10
Diazepam
H2O
Pre-dSPE 3.24 93 7.62
dSPE 3.26 94 4.84
Blood
Pre-dSPE 5.17 149 8.12
dSPE 6.28 182 8.47
Urine
Pre-dSPE 3.81 110 4.15
dSPE 4.42 128 4.63
Flunitrazepam
H2O
Pre-dSPE 2.78 84 5.73
dSPE 2.60 78 4.18
Blood
Pre-dSPE 8.38 253 10.85
dSPE 4.28 129 8.70
Urine
Pre-dSPE 2.77 83 3.68
dSPE 2.81 85 4.32
Medazepam
H2O
Pre-dSPE 1.74 62 3.84
dSPE 2.19 78 3.25
Blood
Pre-dSPE 3.16 112 4.32
dSPE 3.22 115 4.66
Urine
Pre-dSPE 1.45 51 2.26
dSPE 1.54 55 2.44Also, the use of acetonitrile as the extraction solvent allows for
an extract that is compatible with both GC–MS and LC–MS
analyses. The use of the QuEChERS methodology allows for
potential automation, which may yield less operator handling
and higher sample throughput. It also easily allows for various
combinations of clean-up salts and sorbents to be investigated
in an automated fashion, which may allow for improved method
development.
Currently, the initial data has not permitted the understanding of
the matrix related effects. Although, it does demonstrate that ion
enhancement is a possible explanation. This extraction method
warrants replication as well as the investigation of other quantiﬁcation
methods. Along with MSA other quantiﬁcation methods may be
considered. Recovery standard single point quantiﬁcation is a possible
approach, although this is generally considered to be less desirable for
accurate quantiﬁcation and is not advisable for forensic studies.
Another possible approach is to use matrix-matched calibration
standards, similar to what is often used in food commodity analysis.
This approach does require additional preparation of the standards,
and may not be able to adequately reﬂect possible biases in different
matrices (blood, urine, etc.) or possible biases between samples
within the same matrix class.various quantiﬁcation methods.
l STD (RF) Single point
tration (ng/mL) Recovery (%) Area Recovery (%)
259 101,806 346
272 105,068 357
220 432,059 115
140 434,786 115
235 752,168 200
245 938,183 249
120 429,332 7.0
134 517,114 6.4
173 137,063 189
126 123,332 170
328 562,382 777
263 251,405 347
111 120,620 1.8
130 123,605 2.1
137 492,037 56
115 635,109 72
154 941,579 108
166 963,053 110
80 453,900 16
87 543,902 15
Table 5 Concentrations and percent recovery of unknowns
by MSA quantiﬁcation.
Sample Conc. (ng/mL) Recovery (%)
Clonazepam
Blood
Pre-dSPE 0.89 30
dSPE 1.70 56
Urine
Pre-dSPE 8.98 301
dSPE 3.31 111
Diazepam
H2O
Pre-dSPE 1.09 31
dSPE 3.52 102
Blood
Pre-dSPE 1.81 52
dSPE 3.08 89
Urine
Pre-dSPE 2.95 85
dSPE 4.26 123
Flunitrazepam
H2O
Pre-dSPE 0.91 27
dSPE 2.72 82
Blood
Pre-dSPE 2.83 85
dSPE 2.13 64
Urine
Pre-dSPE 1.76 53
dSPE 0.43 13
Medazepam
H2O
Pre-dSPE 1.44 51
dSPE 1.45 51
Blood
Pre-dSPE 1.46 52
dSPE 2.71 96
Urine
Pre-dSPE 1.77 63
dSPE 3.92 140
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